NCT03373201Phase 3Completed
Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
Study sponsor: Vanda Pharmaceuticals
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2018-03-05Actual
Enrollment · participants320Actual
Source updated2023-09-15Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.